Sarepta Therapeutics, Inc.
MX ˙ BMV ˙ US8036071004
SecurityMX:SRPT / Sarepta Therapeutics, Inc.
InstitutionGeode Capital Management, Llc
Latest Disclosed Ownership1,988,796 shares
Latest Disclosed Value $ 43,287,715
Geode Capital Management, Llc reports 4.44% increase in ownership of SRPT / Sarepta Therapeutics, Inc.

On May 15, 2026 - Geode Capital Management, Llc filed a 13F-HR form disclosing ownership of 1,988,796 shares of Sarepta Therapeutics, Inc. (MX:SRPT) valued at $43,287,715 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 1,904,325 shares of Sarepta Therapeutics, Inc.. This represents a change in shares of 4.44% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F SAREPTA THERAPEUTICS COM 803607100 1,988,796 84,471 4.44 43,288 5.60 0.0014
2026-02-09 2025-12-31 13F SAREPTA THERAPEUTICS COM 803607100 1,904,325 183,201 10.64 40,990 23.57 0.0025
2025-11-12 2025-09-30 13F SAREPTA THERAPEUTICS COM 803607100 1,721,124 -154,873 -8.26 33,173 3.39 0.0021
2025-08-08 2025-06-30 13F SAREPTA THERAPEUTICS COM 803607100 1,875,997 55,076 3.02 32,085 -72.40 0.0022
2025-05-13 2025-03-31 13F SAREPTA THERAPEUTICS COM 803607100 1,820,921 114,568 6.71 116,244 -43.99 0.0091
2025-02-12 2024-12-31 13F SAREPTA THERAPEUTICS COM 803607100 1,706,353 9,999 0.59 207,538 -2.06 0.0161
2024-11-12 2024-09-30 13F SAREPTA THERAPEUTICS COM 803607100 1,696,354 44,306 2.68 211,910 -18.84 0.0172
2024-08-09 2024-06-30 13F SAREPTA THERAPEUTICS COM 803607100 1,652,048 131,678 8.66 261,091 32.62 0.0229
2024-05-13 2024-03-31 13F SAREPTA THERAPEUTICS COM 803607100 1,520,370 50,833 3.46 196,867 38.90 0.0182
2024-02-13 2023-12-31 13F SAREPTA THERAPEUTICS COM 803607100 1,469,537 60,762 4.31 141,730 -17.02 0.0148
2023-11-13 2023-09-30 13F SAREPTA THERAPEUTICS COM 803607100 1,408,775 20,692 1.49 170,801 7.45 0.0203
2023-08-11 2023-06-30 13F SAREPTA THERAPEUTICS COM 803607100 1,388,083 126,112 9.99 158,963 -8.61 0.0187
2023-05-15 2023-03-31 13F SAREPTA THERAPEUTICS COM 803607100 1,261,971 43,239 3.55 173,938 110,687.90 0.0226
2023-02-13 2022-12-31 13F SAREPTA THERAPEUTICS COM 803607100 1,218,732 64,434 5.58 158 -99.88 0.0222
2022-11-14 2022-09-30 13F SAREPTA THERAPEUTICS COM 803607100 1,154,298 14,915 1.31 127,596 49.40 0.0194
2022-08-12 2022-06-30 13F SAREPTA THERAPEUTICS COM 803607100 1,139,383 -9,287 -0.81 85,408 -4.82 0.0125
2022-05-13 2022-03-31 13F SAREPTA THERAPEUTICS COM 803607100 1,148,670 16,614 1.47 89,734 -11.97 0.0112
2022-02-11 2021-12-31 13F SAREPTA THERAPEUTICS COM 803607100 1,132,056 147,103 14.94 101,941 11.91 0.0123
2021-11-12 2021-09-30 13F SAREPTA THERAPEUTICS COM 803607100 984,953 665 0.07 91,088 19.04 0.0123
2021-08-13 2021-06-30 13F SAREPTA THERAPEUTICS COM 803607100 984,288 14,525 1.50 76,518 6.00 0.0105
2021-05-12 2021-03-31 13F SAREPTA THERAPEUTICS COM 803607100 969,763 30,880 3.29 72,190 -54.85 0.0110
2021-02-12 2020-12-31 13F SAREPTA THERAPEUTICS COM 803607100 938,883 52,302 5.90 159,879 28.52 0.0268
2020-11-13 2020-09-30 13F SAREPTA THERAPEUTICS COM 803607100 886,581 -6,545 -0.73 124,396 -13.07 0.0244
2020-08-13 2020-06-30 13F SAREPTA THERAPEUTICS COM 803607100 893,126 42,320 4.97 143,091 72.07 0.0306
2020-05-14 2020-03-31 13F SAREPTA THERAPEUTICS COM 803607100 850,806 63,996 8.13 83,158 -18.02 0.0217
2020-02-20 2019-12-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 786,810 28,680 3.78 101,432 77.76 0.0212
2020-02-13 2019-12-31 13F SAREPTA THERAPEUTICS COM 803607100 786,810 28,680 101,432 12,926.6190
2019-11-12 2019-09-30 13F SAREPTA THERAPEUTICS COM 803607100 758,130 15,879 2.14 57,061 -49.41 0.0133
2019-08-14 2019-06-30 13F SAREPTA THERAPEUTICS COM 803607100 742,251 49,567 7.16 112,785 36.61 0.0273
2019-05-14 2019-03-31 13F SAREPTA THERAPEUTICS COM 803607100 692,684 33,931 5.15 82,560 14.84 0.0214
2019-03-06 2018-12-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 658,753 67,601 11.44 71,889 -24.70 0.0222
2019-02-13 2018-12-31 13F SAREPTA THERAPEUTICS COM 803607100 658,753 67,601 71,889
2018-11-13 2018-09-30 13F SAREPTA THERAPEUTICS COM 803607100 591,152 13,587 2.35 95,476 25.06 0.0269
2018-08-14 2018-06-30 13F SAREPTA THERAPEUTICS COM 803607100 577,565 -1,827 -0.32 76,342 77.84 0.0235
2018-05-15 2018-03-31 13F SAREPTA THERAPEUTICS COM 803607100 579,392 19,936 3.56 42,927 37.90 0.0140
2018-02-13 2017-12-31 13F SAREPTA THERAPEUTICS COM 803607100 559,456 13,631 2.50 31,128 25.73 0.0106
2017-11-14 2017-09-30 13F SAREPTA THERAPEUTICS COM 803607100 545,825 99,556 22.31 24,758 64.58 0.0091
2017-08-14 2017-06-30 13F SAREPTA THERAPEUTICS COM 803607100 446,269 25,222 5.99 15,043 20.71 0.0059
2017-06-21 2017-03-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 421,047 29,603 7.56 12,462 16.07 0.0051
2017-05-12 2017-03-31 13F SAREPTA THERAPEUTICS COM 803607100 421,047 12,462
2017-02-14 2016-12-31 13F SAREPTA THERAPEUTICS COM 803607100 391,444 41,926 12.00 10,737 -49.97 0.0050
2016-11-10 2016-09-30 13F SAREPTA THERAPEUTICS COM 803607100 349,518 55,080 18.71 21,462 282.29 0.0108
2016-08-12 2016-06-30 13F SAREPTA THERAPEUTICS COM 803607100 294,438 12,146 4.30 5,614 1.89 0.0031
2016-05-13 2016-03-31 13F SAREPTA THERAPEUTICS COM 803607100 282,292 -2,489 -0.87 5,510 -49.85 0.0029
2016-02-12 2015-12-31 13F SAREPTA THERAPEUTICS COM 803607100 284,781 34,677 13.87 10,986 36.81 0.0063
2015-11-13 2015-09-30 13F SAREPTA THERAPEUTICS COM 803607100 250,104 6,531 2.68 8,030 8.35 0.0049
2015-08-14 2015-06-30 13F SAREPTA THERAPEUTICS COM 803607100 243,573 19,384 8.65 7,411 148.94 0.0042
2015-05-14 2015-03-31 13F SAREPTA THERAPEUTICS COM 803607100 224,189 6,614 3.04 2,977 -5.43 0.0017
2015-02-12 2014-12-31 13F SAREPTA THERAPEUTICS COM 803607100 217,575 1,631 0.76 3,148 -30.89 0.0019
2014-11-14 2014-09-30 13F SAREPTA THERAPEUTICS COM 803607100 215,944 -1,853 -0.85 4,555 -29.79 0.0030
2014-08-13 2014-06-30 13F SAREPTA THERAPEUTICS COM 803607100 217,797 24,959 12.94 6,488 40.04 0.0042
2014-05-14 2014-03-31 13F SAREPTA THERAPEUTICS COM 803607100 192,838 21,025 12.24 4,633 32.41 0.0031
2014-02-14 2013-12-31 13F SAREPTA THERAPEUTICS COM 803607100 171,813 27,933 19.41 3,499 -48.51 0.0024
2013-11-14 2013-09-30 13F SAREPTA THERAPEUTICS COM 803607100 143,880 18,442 14.70 6,795 42.36 0.0054
2013-08-14 2013-06-30 13F SAREPTA THERAPEUTICS COM 803607100 125,438 125,438 4,773 0.0042
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.